Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS).
Journal: Cancer
Published: March 11, 2021
An inhibitor of proteasome β2 sites sensitizes myeloma cells to immunoproteasome inhibitors.
Journal: Blood advances
Published: January 19, 2018
Showing 1-2 of 2
Last Updated: 09/26/2026